Synthesis of the 6-6-6 tricyclic skeleton of the anti-influenza A diterpene wickerol A

Tetrahedron Letters

Volumn 55, Issue 14, 2014, Pages 2183-2186

  Kwong Jia Ye, Danson ^a   Richard, Jean Alexandre ^a  

^a INSTITUTE OF CHEMICAL AND ENGINEERING SCIENCES   (Singapore)

Author keywords

Antivirals; Diterpene; Influenza A; Natural products; Wickerol A

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; CARBENE; DITERPENE; OSELTAMIVIR; PROLINE; UNCLASSIFIED DRUG; WICKEROL A; WICKEROL B; ZANAMIVIR;

ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CATALYST; CONTROLLED STUDY; DRUG SYNTHESIS; DRUG TRANSFORMATION; IC 50; INFLUENZA A; INFLUENZA VIRUS A; MICHAEL ADDITION; NONHUMAN; ROBINSON ANNULATION; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; TRICHODERMA ATROVIRIDE;

EID: 84897454163     PISSN: 00404039     EISSN: 18733581     Source Type: Journal    
DOI: 10.1016/j.tetlet.2014.02.045     Document Type: Article

References (43)

1. April 2009 figures from the World Health Organization (WHO) website: http://www.who.int/mediacentre/factsheets/fs211/en/index.html.
2. N.J. Cox, and K. Subbarao Annu. Rev. Med. 51 2000 407 421
3. The 'Spanish' flu killed 3% of the world population (i.e., fifty million people) but only 10% of the people infected: N.P.A.S. Johnson, and J. Mueller Bull. Hist. Med. 76 2002 105 115
4. 'Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2013'. October 8, 2013 update: http://www.who.int/entity/ influenza/human-animal-interface/EN-GIP-20131008CumulativeNumberH5N1cases.pdf.
5. For recent reports on the airborne transmission of avian influenza, see: M. Imai, T. Watanabe, M. Hatta, S.C. Das, M. Ozawa, K. Shinya, G. Zhong, A. Hanson, H. Katsura, S. Watanabe, C. Li, E. Kawakami, S. Yamada, M. Kiso, Y. Suzuki, E.A. Maher, G. Neumann, and Y. Kawaoka Nature 486 2012 420 430
6. S. Herfst, E.J.A. Schrauwen, M. Linster, S. Chutinimitkul, E. de Wit, V.J. Munster, E.M. Sorrell, T.M. Bestebroer, D.F. Burke, D.J. Smith, G.F. Rimmelzwaan, A.D.M.E. Osterhaus, and R.A.M. Fouchier Science 336 2012 1534 1541
7. C.A. Russel, J.M. Fonville, A.E.X. Brown, D.F. Burke, D.L. Smith, S.L. James, S. Herfst, S. van Boheemen, M. Linster, E.J. Schrauwren, L. Katzelnick, A. Mosterin, T. Kuiken, E. Maher, G. Neumann, A.D.M.E. Osterhaus, Y. Kawaoka, R.A.M. Fouchier, and D.J. Smith Science 336 2012 1541 1547
8. J. Du, T.A. Cross, and H.-X. Zhou Drug Discovery Today 17 2012 1111 1120
9. K. Das J. Med. Chem. 55 2012 6263 6277
10. For the development of new antivirals, see: E. De Clercq Nat. Rev. Drug Disc. 5 2006 1015 1025
11. J.S. Oxford, and A. Galbraith Pharm. Ther. 11 1980 181 262
12. J. Magano Chem. Rev. 109 2009 4398 4438
13. V.M. Deyde, X. Xu, R.A. Bright, M. Shaw, C.B. Smith, Y. Zhang, Y. Shu, L.V. Gubareva, N.J. Cox, and A.I. Klimov J. Infect. Dis. 196 2007 249 257
14. U. Grienke, M. Schmidtke, S. von Grafenstein, J. Kirchmair, K.R. Liedl, and J.M. Rollinger Nat. Prod. Rep. 29 2012 11 36
15. E. Feng, D. Ye, J. Li, D. Zhang, J. Wang, F. Zhao, R. Hilgenfeld, M. Zheng, H. Jiang, and H. Liu ChemMedChem 7 2012 1527 1536
16. T. Yamamoto, N. Izumi, H. Ui, A. Sueki, R. Masuma, K. Nonaka, T. Hirose, T. Sunazuka, T. Nagai, H. Yamada, S. Omura, and K. Shiomi Tetrahedron 68 2012 9267 9271
17. L. Dong, L. Deng, Y.H. Lim, G.Y.C. Leung, and D.Y.-K. Chen Chem. Eur. J. 17 2011 5778 5781
18. G.A. Kraus, and Y.-S. Hon J. Am. Chem. Soc. 107 1985 4341 4342
19. G.A. Kraus, and Y.-S. Hon J. Org. Chem. 50 1985 4605 4608
20. C. Lohoelter, D. Schollmeyer, and S.R. Waldvogel Eur. J. Org. Chem. 2012 6364 6371
21. R.M.A. Lavigne, M. Riou, M. Girardin, L. Morency, and L. Barriault Org. Lett. 7 2005 5921 5923
22. D. Seebach, and D. Enders Angew. Chem. Int. Ed. 14 1975 15 32
23. D. Seebach Angew. Chem. Int. Ed. 18 1979 239 258
24. T.R. Hoye, and M.J. Kurth Tetrahedron Lett. 24 1983 4769 4772
25. B.J.M. Jansen, C.C.J. Hendrikx, N. Masalov, G.A. Stork, T.M. Meulemans, F.Z. Macaev, and A. de Groot Tetrahedron 56 2000 2075 2094
26. For a recent review, see: B. Bradshaw, and J. Bonjoch Synlett 2012 337 356
27. D. Rajagopal, K. Rajagopalan, and S. Swaminathan Tetrahedron: Asymmetry 7 1996 2189 2190
28. D. Rajagopal, R. Narayanan, and S. Swaminathan Tetrahedron Lett. 42 2001 4887 4890
29. For a remarkable l-proline-mediated Robinson annulation in the enantioselective formal synthesis of (-)-platensimycin, see: P. Li, J.N. Payette, and H. Yamamoto J. Am. Chem. Soc. 129 2007 9534 9535
30. For a review on this class of organocatalysts, see: K.L. Jensen, G. Dickmeiss, H. Jiang, L. Albrecht, and K.A. Jørgensen Acc. Chem. Res. 45 2012 248 264
31. X.-M. Zhang, M. Wang, Y.-Q. Tu, C.-A. Fan, Y.-J. Jiang, S.-Y. Zhang, and F.-M. Zhang Synlett 2008 2831 2835
32. L. Trzoss, J. Xu, M.H. Lacoske, and E.A. Theodorakis Beilstein J. Org. Chem. 9 2013 1135 1140
33. G. Lelais, and D.W.C. MacMillan Aldrichim. Acta 39 2006 79 87
34. T. Poisson Synlett 2008 147 148
35. S. Bahmanyar, and K.N. Houk J. Am. Chem. Soc. 123 2001 12911 12912
36. L. Hoang, S. Bahmanyar, K.N. Houk, and B. List J. Am. Chem. Soc. 125 2003 16 17
37. D.G. Blackmond, A. Moran, M. Hughes, and A. Armstrong J. Am. Chem. Soc. 132 2010 7598 7599
38. J.E. Hein, J. Burés, Y.-H. Lam, M. Hughes, K.N. Houk, A. Armstrong, and D.G. Blackmond Org. Lett. 13 2011 5644 5647
39. For a synthetic application, see: S. Abele, R. Inauen, D. Spielvogel, and C. Moessner J. Org. Chem. 77 2012 4765 4773
40. H. Stetter Angew. Chem., Int. Ed. 15 1976 639 647
41. J.R. de Alaniz, and T. Rovis Synlett 2009 1189 1207
42. For a review on samarium(II) iodide mediated cyclizations, see: D.J. Edmonds, D. Johnston, and D.J. Procter Chem. Rev. 104 2004 3371 3403
43. M.S. Kerr, J.R. de Alaniz, and T. Rovis J. Org. Chem. 70 2005 5725 5728